Tracking lymphocytes in vivo

Archivum Immunologiae et Therapiae Experimentalis

Volumn 52, Issue 3, 2004, Pages 173-187

  Adams, Claire L ^a   Kobets, Natalie ^a   Meiklejohn, Gordon R ^a   Millington, Owain R ^a   Grierson, Angela M ^a   Rush, Catherine M ^a   Smith, Karen M ^a   Garside, Paul ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Adoptive transfer; Ag specific; Cellular interactions; Fluorescence; Lymphocytes; Transgenic

Indexed keywords

CHEMOKINE;

ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOIMMUNITY; CELL ACTIVATION; CELL CYCLE; CELL INTERACTION; CYTOMETRY; FLUORESCENCE; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE; NONHUMAN; REVIEW; T LYMPHOCYTE SUBPOPULATION; ANIMAL; ANTIGEN PRESENTATION; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGICAL TOLERANCE; LASER SCANNING CYTOMETRY; METABOLISM; METHODOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNE TOLERANCE; LASER SCANNING CYTOMETRY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 7044248380     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (164)

1. Abbas A. K., Murphy K. M. and Sher A. (1996): Functional diversity of helper T lymphocytes. Nature, 383, 787-793.
2. Akbari O., Freeman G. J., Meyer E. H., Greenfield E. A., Chang T. T., Sharpe A. H., Berry G., DeKruyff R. H. and Umetsu D. T. (2002): Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med., 8, 1024-1032.
3. Ando K., Guidotti L. G., Wirth S., Ishikawa T., Missale G., Moriyama T., Schreiber R. D., Schlicht H. J., Huang S. N. and Chisari F. V. (1994): Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol., 152, 3245-3253.
4. Ansel K. M., McHeyzer-Williams L. J., Ngo V. N., McHeyzer-Williams M. G. and Cyster J. G. (1999): In vivo-activated CD4 T cells upregulate CXC chemokinc receptor 5 and reprogram their response to lymphoid chemokines. J. Exp. Med., 190, 1123-1134.
5. Banchereau J. and Steinman R. M. (1998): Dendritic cells and the control of immunity. Nature, 392, 245-252.
6. Bedner E., Li X., Kunicki J. and Darzymkiewicz Z. (2000): Translocation of Bax to mitochondria during apoptosis measured by laser scanning cytometry. Cytometry, 41, 83-88.
7. + DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties. Immunology, 108, 481-492.
8. Bilsborough J. and Viney J. L. (2002): Getting to the guts of immune regulation. Immunology, 106, 139-143.
9. Bird J. J., Brown D. R., Mullen A. C., Moskowitz N. H., Mahowald M. A., Sider J. R., Gajewski T. F., Wang C. R. and Reiner S. L. (1998): Helper T cell differentiation is controlled by the cell cycle. Immunity, 9, 229-237.
10. + T cells. J. Immunol., 164, 2890-2896.
11. Bleesing J. J. and Cooper E. (2003): Autoimmune lymphoproliferative syndrome (ALPS). Curr. Pharm. Des., 9, 265-278.
12. Bonnevier J. L. and Mueller D. L. (2002): Cutting edge: B7/CD28 interactions regulate cell cycle progression independent of the strength of TCR signaling. J. Immunol., 169, 6659-6663.
13. Bromley S. K., Burack W. R., Johnson K. G., Somersalo K., Sims T. N., Sumen C., Davis M. M., Shaw A. S., Allen P. M. and Dustin M. L. (2001): The immunological synapse. Annu. Rev. Immunol., 19, 375-396.
14. Cahalan M. D., Parker I., Wei S. H. and Miller M. J. (2002): Two-photon tissue imaging: seeing the immune system in a fresh light. Nat. Rev. Immunol., 2, 872-880.
15. + T cells specific for an antigen expressed in Escherichia coli. J. Immunol., 160, 3462-3470.
16. Cohen G. M. (1997): Caspases: the executioners of apoptosis. Biochem. J., 326 (Pt 1), 1-16.
17. Colantonio L., Recalde H., Sinigaglia F. and D'Ambrosio D. (2002): Modulation of chemokine receptor expression and chemotactic responsiveness during differentiation of human naive T cells into Th1 or Th2 cells. Eur. J. Immunol., 32, 1264-1273.
18. Coles R. M., Mueller S. N., Heath W. R., Carbone F. R. and Brooks A. G. (2002): Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1. J. Immunol., 168, 834-838.
19. Cornall R. J., Goodnow C. C. and Cyster J. G. (1995): The regulation of self-reactive B cells. Curr. Opin. Immunol., 7, 804-811.
20. Coyle A. J. and Gutierrez-Ramos J. C. (2001): The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat. Immunol., 2, 203-209.
21. Cyster J. G. (1999): Chemokines and cell migration in secondary lymphoid organs. Science, 286, 2098-2102.
22. Cyster J. G. (1999): Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J. Exp. Med., 189, 447-450.
23. Cyster J. G. (1997): Signaling thresholds and interclonal competition in preimmune B-cell selection. Immunol. Rev., 156, 87-101.
24. Cyster J. G. and Goodnow C. C. (1995): Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity, 3, 691-701.
25. Cyster J. G., Hartley S. B. and Goodnow C. C. (1994): Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature, 371, 389-395.
26. Deenick E. K., Hasbold J. and Hodgkin P. D. (1999): Switching to IgG3, IgG2b, and IgA is division linked and independent, revealing a stochastic framework for describing differentiation. J. Immunol., 163, 4707-4714.
27. Deptala A., Bedner E., Gorczyca W. and Darzymkiewicz Z. (1998): Activation of nuclear factor κB (NF-κB) assayed by LSC. Cytometry, 33, 376-382.
28. Dieu M. C., Vanbervliet B., Vicari A., Bridon J. M., Oldham E., Ait-Yahia S., Briere F., Zlotnik A., Lebecque S. and Caux C. (1998): Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med., 188, 373-386.
29. Fadok V. A. and Chimini G. (2001): The phagocytosis of apoptotic cells. Semin. Immunol., 13, 365-372.
30. Fazekas de St Groth B., Smith A. L., Koh W. P., Girgis L., Cook M. C. and Bertolino P. (1999): Carboxyfluorescein diacetate succinimidyl ester and the virgin lymphocyte: a marriage made in heaven. Immunol. Cell. Biol., 77, 530-538.
31. Fowler S. and Powrie F. (2002): CTLA-4 expression on antigen-specific cells but not IL-10 secretion is required for oral tolerance. Eur. J. Immunol., 32, 2997-3006.
32. Fraser S. A., de Haan L., Hearn A. R., Bone H. K., Salmond R. J., Rivett A. J., Williams N. A. and Hirst T. R. (2003): Mutant Escherichia coli heat-labile toxin B subunit that separates toxoid-mediated signaling and immunomodulatory action from trafficking and delivery functions. Infect. Immun., 71, 1527-1537.
33. Friedman A. and Weiner H. L. (1994): Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA, 91, 6688-6692.
34. Fulcher D. A., Lyons A. B., Korn S. L., Cook M. C., Koleda C., Parish C., Fazekas de St Groth B. and Basten A. (1996): The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J. Exp. Med., 183, 2313-2328.
35. Garside P., Ingulli E., Merica R. R., Johnson J. G., Noelle R. J. and Jenkins M. K. (1998): Visualisation of specific B and T lymphocyte interactions in the lymph node. Science, 281, 96-99.
36. Garside P. and Mowat A. M. (2001): Oral tolerance. Semin. Immunol., 13, 177-185.
37. Gett A. V. and Hodgkin P. D. (1998): Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation. Proc. Natl. Acad. Sci. USA, 95, 9488-9493.
38. Goodnow C. C., Crosbie J., Adelstein S., Lavoie T. B., Smith-Gill S. J., Brink R. A., Pritchard-Briscoe H., Wotherspoon J. S., Loblay R. H., Raphael K., Trent R. J. and Basten A. (1988): Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature, 334, 676-682.
39. Grakoui A., Bromley S. K., Sumen C., Davis M. M., Shaw A. S., Allen P. M. and Dustin M. L. (1999): The immunological synapse. A molecular machine controlling T-cell activation. Science, 285, 221-227.
40. + T cells during viral infection. J. Immunol., 170, 4745-4751.
41. Grohmann U., Van Snick J., Campanile F., Silla S., Giampietri A., Vacca C., Renauld J. C., Fioretti M. C. and Puccetti P. (2000): IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-α, IL-12, and IFN-γ, and induction of IL-10. J. Immunol., 164, 4197-4203.
42. Gulbranson-Judge A. and MacLennan I. (1996): Sequential antigen-specific growth of T cells in the T zones and follicles in response to pigeon cytochrome c. Eur. J. Immunol., 26, 1830-1837.
43. Guzman-Rojas L., Sims-Mourtada J. C., Rangel R. and Martinez-Valdez H. (2002): Life and death within germinal centres: a double-edged sword. Immunology, 107, 167-175.
44. Harriague J. and Bismuth G. (2002): Imaging antigen-induced PI3K activation in T cells. Nat. immunol., 3, 1090-1096.
45. Hasbold J., Gett A. V., Rush J. S., Deenick E., Avery D., Jun J. and Hodgkin P. D. (1999): Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester. Immunol. Cell Biol., 77, 516-522.
46. Hasbold J., Lyons A. B., Kehry M. R. and Hodgkin P. D. (1998): Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4. Eur. J. Immunol., 28, 1040-1051.
47. Haskins K., Kubo R., White J., Pigeon M., Kappler J. and Marrack P. (1983): The major histocompatibility complex-restricted antigen receptor on T-cells. I. Isolation with a monoclonal antibody. J. Exp. Med., 157, 1149-1169.
48. Hibbert L. and Johnston J. A. (2001): Cytokine signalling and disease. Expert Opin. Ther. Targets, 5, 641-653.
49. Hildeman D., Zhu Y., Mitchell T., Kappler J. and Marrack P. (2002): Molecular mechanisms of activated T cell death in vivo. Curr. Opin. Immunol., 14, 354-359.
50. Hill N. J., Van Gunst K. and Sarvetnick N. (2003): Th1 and Th2 pancreatic inflammation differentially affects homing of islet-reactive CD4 cells in nonobese diabetic mice. J. Immunol., 170, 1649-1658.
51. Holcombe H., Mellman I., Janeway C. A. Jr., Bottomly K. and Dittel B. N. (2002): The immunosuppressive agent 15-deoxyspergualin functions by inhibiting cell cycle progression and cytokine production following naive T cell activation. J. Immunol., 169, 4982-4989.
52. + T cells pass through an effector phase during the process of in vivo tolerance induction. J. Immunol., 170, 3945-3953.
53. Hunter T. (2000): Signalling-2000 and beyond. Cell, 100, 113-127.
54. + dendritic cells and antigen-specific CD4 T cells after subcutaneous injection of antigen. J. Immunol., 169, 2247-2252.
55. Iqbal N., Oliver J. R., Wagner F. H., Lazenby A. S., Elson C. O. and Weaver C. T. (2002): T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis. J. Exp. Med., 195, 71-84.
56. Itano A. A., McSorley S. J., Reinhardt R. L., Ehst B. D., Ingulli E., Rudensky A. Y. and Jenkins M. K. (2003): Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity, 19, 47-57.
57. +, and double-negative Peyer's patch dendritic cells. J. Immunol., 166, 4884-4890.
58. Iwasaki A. and Kelsall B. L. (1999): Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med., 190, 229-239.
59. Jacob J., Kassir R. and Kelsoe G. (1991): In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J. Exp. Med., 173, 1165-1175.
60. Jendro M. C., Kohler L., Kuipers J. G. and Zeidler H. (2002): Microbe-induced T cell apoptosis: subversion of the host defense system? FEMS Microbiol. Lett., 207, 121-126.
61. Jenkins M. K., Khoruts A., Ingulli E., Mueller D. L., McSorley S. J., Reinhardt R. L., Itano A. and Pape K. A. (2001): In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol., 19, 23-45.
62. + T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol., 2, 415-422.
63. Kaech S. M., Hemby S., Kersh E. and Ahmed R. (2002): Molecular and functional profiling of memory CD8 T cell differentiation. Cell, 111, 837-851.
64. Kaech S. M., Wherry E. J. and Ahmed R. (2002): Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol., 2, 251-262.
65. Kaji T., Hachimura S., Ise W. and Kaminogawa S. (2003): Proteome analysis reveals caspase activation in hyporesponsive CD4 T lymphocytes induced in vivo by the oral administration of antigen. J. Biol. Chem., 278, 27836-27843.
66. Kamentsky L. (2001): Laser scanning cytometry. Methods Cell Biol., 63, 51-87.
67. Kamentsky L. A. and Kamentsky L. D. (1991): Microscope-based multiparameter laser scanning cytometer yielding data comparable to flow cytometry data. Cytometry, 12, 381-387.
68. Kearney E., Pape K., Loh D. and Jenkins M. (1994): Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity, 1, 327-339.
69. Kelsoe G. (1996): The germinal center: a crucible for lymphocyte selection. Semin. Immunol., 8, 179-184.
70. Kerr J. F. (1971): Shrinkage necrosis: a distinct mode of cellular death. J. Pathol., 105, 13-20.
71. Khoruts A., Mondino A., Pape K. A., Reiner S. L. and Jenkins M. K. (1998): A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J. Exp. Med., 187, 225-236.
72. Kim C. H., Pelus L. M., White J. R., Applebaum E., Johanson K. and Broxmeyer H. E. (1998): CKβ-11/macrophage inflammatory protein-3β/ EBI1-Iigand chemokine is an efficacious chemoattractant for T and B cells. J. Immunol., 160, 2418-2424.
73. Kim S. K., Reed D. S., Heath W. R., Carbone F. and Lefrancois L. (1997): Activation and migration of CD8 T cells in the intestinal mucosa. J. Immunol., 159, 4295-4306.
74. Kluck R. M., Bossy-Wetzel E., Green D. R. and Newmeyer D. D. (1997): The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science, 275, 1132-1136.
75. Kobets N., Kennedy K. and Garside P. (2003): An investigation of the distribution of antigen fed in tolerogenic or immunogenic forms. Immunol. Lett., 88, 147-155.
76. Krummel M., Wulfing C., Sumen C. and Davis M. M. (2000): Thirty-six views of T-cell recognition. Philos. Trans. R Soc. Lond. B Biol. Sci., 355, 1071-1076.
77. Krummel M. F., Sjaastad M. D., Wulfing C. and Davis M. M. (2000): Differential clustering of CD4 and CD3ζ during T cell recognition. Science, 289, 1349-1352.
78. Krzysiek R., Lefevre E.A., Zou W., Foussat A., Bernard J., Portier A., Galanaud P. and Richard Y. (1999): Antigen receptor engagement selectively induces macrophage inflammatory protein-1α (MIP-1α) and MIP-1β chemokine production in human B cells. J. Immunol., 162, 4455-4463.
79. Kurosaki T. (2002): Regulation of B cell fates by BCR signaling components. Curr. Opin. Immunol., 14, 341-347.
80. Kurts C., Heath W. R., Carbone F. R., Allison J., Miller J. F. and Kosaka H. (1996): Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med., 184, 923-930.
81. Lambrecht B. N., Pauwels R. A. and Fazekas De St Groth B. (2000): Induction of rapid T cell activation, division, and recirculation by intratracheal injection of dendritic cells in a TCR transgenic model. J. Immunol., 164, 2937-2946.
82. Lee K. H., Holdorf A. D., Dustin M. L., Chan A. C., Allen P. M. and Shaw A. S. (2002): T cell receptor signaling precedes immunological synapse formation. Science, 295, 1539-1542.
83. + T cell clonal expansion. J. Immunol., 168, 1682-1689.
84. Lefrancois L., Marzo A. and Williams K. (2003): Sustained response initiation is required for T cell clonal expansion but not for effector or memory development in vivo. J. Immunol., 171, 2832-2839.
85. Lens S. M., den Drijver B. F., Potgens A. J., Tesselaar K., van Oers M. H. and van Lier R. A. (1998): Dissection of pathways leading to antigen receptor-induced and Fas/CD95-induced apoptosis in human B cells. J. Immunol., 160, 6083-6092.
86. Leonard W. J. (2001): Cytokines and immunodeficiency diseases. Nat. Rev. Immunol., 1, 200-208.
87. + T cells. Science, 271, 1272-1276.
88. Li X. and Darzynkiewicz Z. (1995): Labelling DNA strand breaks with BrdUTP. Detection of apoptosis and cell proliferation. Cell Prolif., 28, 571-579.
89. Liu Y. J., Zhang J., Lane P. J., Chan E. Y. and MacLennan I. C. (1991): Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur. J. Immunol., 21, 2951-2962.
90. Lyons A. B. and Parish C. R. (1994): Determination of lymphocyte division by flow cytometry. J. Immunol. Methods, 171, 131-137.
91. MacLennan I. C. (1994): Germinal centers. Annu. Rev. Immunol., 12, 117-139.
92. - dendritic cells in the induction of primary immune responses in vivo. J. Leukoc. Biol., 66, 242-246.
93. Manickasingham S. P., Edwards A. D., Schulz O. and Reis e Sousa C. (2003): The ability of murine dendritic cell subsets to direct T helper cell differentiation is dependent on microbial signals. Eur. J. Immunol., 33, 101-107.
94. Marchant J. S., Stutzmann G. E., Leissring M. A., LaFerla F. M. and Parker I. (2001): Multiphoton-evoked color change of DsRed as an optical highlighter for cellular and subcellular labeling. Nat. Biotechnol., 19, 645-649.
95. Martin S. J., Reutelingsperger C. P., McGahon A. J., Rader J. A., van Schie R. C., LaFace D. M. and Green D. R. (1995): Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med., 182, 1545-1556.
96. McSorley S., Asch S., Costalonga M., Reinhardt R. and Jenkins M. (2002): Tracking Salmonella-specific CD4 T-cells in vivo reveals a local mucosal response to a disseminated infection. Immunity, 16, 365-377.
97. Miller M. J., Wei S. H., Cahalan M. D. and Parker I. (2003): Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy. Proc. Natl. Acad. Sci. USA, 100, 2604-2609.
98. Miller M. J., Wei S. H., Parker I. and Cahalan M. D. (2002): Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science, 296, 1869-1873.
99. Mintern J., Li M., Davey G. M., Blanas E., Kurts C., Carbone F. R. and Heath W. R. (1999): The use of carboxyfluorescein diacetate succinimidyl ester to determine the site, duration and cell type responsible for antigen presentation in vivo. Immunol Cell Biol., 77, 539-543.
100. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A. and Coffman R. L. (1986): Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol., 136, 2348-2357.
101. Mountz J. D., Wu J., Cheng J. and Zhou T. (1994): Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum., 37, 1415-1420.
102. Murphy L. O., Smith S., Chen R. H., Fingar D. C. and Blenis J. (2002): Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol., 4, 556-564.
103. Naramura M., Hu R. J. and Gu H. (1998): Mice with a fluorescent marker for interleukin 2 gene activation. Immunity, 9, 209-216.
104. Ngo V. N., Tang H. L. and Cyster J. G. (1998): Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J. Exp. Med., 188, 181-191.
105. + T cells by infected dendritic cells in vivo. Nat. Immunol., 3, 265-271.
106. O'Garra A. (1998): Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity, 8, 275-283.
107. O'Garra A. and Murphy K. (1994): Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol., 6, 458-466.
108. Ohashi P. S. (2002): T-cell signalling and autoimmunity: molecular mechanisms of disease. Nat. Rev. Immunol., 2, 427-438.
109. Okada T., Lian Z. X., Naiki M., Ansari A. A., Ikehara S. and Gershwin M. E. (2003): Murine thymic plasmacytoid dendritic cells. Eur. J. Immunol., 33, 1012-1019.
110. Okada T., Ngo V. N., Ekland E. H., Forster R., Lipp M., Littman D. R. and Cyster J. G. (2002): Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J. Exp. Med., 196, 65-75.
111. Owen-Schaub L. B., Yonehara S., Crump W. L. 3rd and Grimm E. A. (1992): DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol., 140, 197-205.
112. Pape K., Kearney E., Khoruts A., Mondino A., Merica R., Chen Z., Ingulli E., White J., Johnson J. and Jenkins M. (1997): Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cell for the study of T-cell activation in vivo. Immunol. Rev., 156, 67-78.
113. + T cells persist in vivo following induction of peripheral tolerance. J. Immunol., 160, 4719-4729.
114. Paul W. E. and Seder R. A. (1994): Lymphocyte responses and cytokines. Cell, 76, 241-251.
115. + dendritic cells. J. Immunol., 166, 5327-5330.
116. Poudrier J., van Essen D., Morales-Alcelay S., Leanderson T., Bergthorsdottir S. and Gray D. (1998): CD40 ligand signals optimize T helper cell cytokine production: role in Th2 development and induction of germinal centers. Eur. J. Immunol., 28, 3371-3383.
117. Pulendran B., Smith J. L., Caspary G., Brasel K., Pettit D., Maraskovsky E. and Maliszewski C. R. (1999): Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA, 96, 1036-1041.
118. Randolph D. A., Huang G., Carruthers C. J., Bromley L. E. and Chaplin D. D. (1999): The role of CCR7 in TH1 and TH2 cell localization and delivery of B cell help in vivo. Science, 286, 2159-2162.
119. Reape T. J., Rayner K., Manning C. D., Gee A. N., Barnette M. S., Burnand K. G. and Groot P. H. (1999): Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. Am. J. Pathol., 154, 365-374.
120. Reinhardt R. L., Bullard D. C., Weaver C. T. and Jenkins M. K. (2003): Preferential accumulation of antigen-specific effector CD4 T cells at an antigen injection site involves CD62E-dependent migration but not local proliferation. J. Exp. Med., 197, 751-762.
121. Reis e Sousa C. and Germain R. N. (1999): Analysis of adjuvant function by direct visualization of antigen presentation in vivo: endotoxin promotes accumulation of antigen-bearing dendritic cells in the T cell areas of lymphoid tissue. J. Immunol., 162, 6552-6561.
122. Romagnani S. (1994): Lymphokine production by human T cells in disease states. Annu. Rev. Immunol., 12, 227-257.
123. Rossi D. L., Vicari A. P., Franz-Bacon K., McClanahan T. K. and Zlotnik A. (1997): Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3α and MIP-3β. J. Immunol., 158, 1033-1036.
124. + T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways. J. Immunol., 169, 4951-4960.
125. Saito T. and Yamasaki S. (2003): Negative feedback of T cell activation through inhibitory adapters and costimulatory receptors. Immunol. Rev., 192, 143-160.
126. Sallusto F., Schaerli P., Loetscher P., Schaniel C., Lenig D., Mackay C. R., Qin S. and Lanzavecchia A. (1998): Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol., 28, 2760-2769.
127. Schaniel C., Pardali E., Salluslo F., Speletas M., Ruedl C., Shimizu T., Seidl T., Andersson J., Melchers F., Rolink A. G. and Sideras P. (1998): Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. J. Exp. Med., 188, 451-463.
128. Schroder M., Meisel C., Buhl K., Profanter N., Sievert N., Volk H. D. and Grutz G. (2003): Different modes of IL-10 and TGF- β to Inhibit cytokine-dependent IFN-γ production: consequences for reversal of lipopolysaccharide desensitization. J. Immunol., 170, 5260-5267.
129. Sharpe A. H. and Freeman G. J. (2002): The B7-CD28 superfamily. Nat. Rev. Immunol., 2, 116-126.
130. Shortman K. and Caux C. (1997): Dendritic cell development: multiple pathways to nature's adjuvants. Stem Cells, 15, 409-419.
131. Smith K. M., Brewer J. M., Webb P., Coyle A.J., Gutierrez-Ramos C. and Garside P. (2003): Inducible costimulatory molecule-b7-related protein 1 interactions are important for the clonal expansion and B cell helper functions of naive, Th1, and th2 T cells. J. Immunol., 170, 2310-2315.
132. Smith K. M., Davidson J. M. and Garside P. (2002): T-cell activation occurs simultaneously in local and peripheral lymphoid tissue follow ing oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division. Immunology, 106, 144-158.
133. Smith K. M., McAskill F. and Garside P. (2002): Orally tolerized T cells are only able to enter B cell follicles following challenge with antigen in adjuvant, but they remain unable to provide B cell help. J. Immunol., 168, 4318-4325.
134. + T cells provide help for B cell expansion and antibody synthesis in a similar manner in vivo. J. Immunol., 165, 3136-3144.
135. Starr T. K., Jameson S. C. and Hogquist K. A. (2003): Positive and negative selection of T cells. Annu. Rev. Immunol., 21, 139-176.
136. Stoll S., Delon J., Brotz T. M. and Germain R. N. (2002): Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science, 296, 1873-1876.
137. Sun J., Dirden-Kramer B., Ito K., Ernst P. B. and Van Houten N. (1999): Antigen-specific T cell activation and proliferation during oral tolerance induction. J. Immunol., 162, 5868-5875.
138. Suss G. and Shortman K. (1996): A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med., 183, 1789-1796.
139. Thompson C. B. (1995): Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462.
140. +CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol., 167, 188-195.
141. Trapani J. A., Jans D. A., Jans P. J., Smyth M. J., Browne K. A. and Sutton V. R. (1998): Efficient nuclear targeting of granzyme B and the nuclear consequences of apoptosis induced by granzyme B and perform are caspase-dependent, but cell death is caspase-independent. J. Biol. Chem., 273, 27934-27938.
142. Trombetta E. S., Ebersold M., Garrett W., Pypaert M. and Mellman I. (2003): Activation of lysosomal function during dendritic cell maturation. Science, 299, 1400-1403.
143. + dendritic cells in vivo. J. Exp. Med., 195, 683-694.
144. Van der Merwe P. A. (2002): Formation and function of the immunological synapse. Curr. Opin. Immunol., 14, 293-298.
145. Van Engeland M., Ramaekers F. C., Schutte B. and Reutelingsperger C. P. (1996): A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry, 24, 131-139.
146. Van Houten N. and Blake S. F. (1996): Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J. Immunol., 157, 1337-1341.
147. Van Parijs L., Peterson D. A. and Abbas A. K. (1998): The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity, 8, 265-274.
148. Van Stipdonk M. J., Lemmens E. E. and Schoenberger S. P. (2001): Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol., 2, 423-429.
149. Vermes I., Haanen C., Steffens-Nakken H. and Reutelingsperger C. (1995): A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods, 184, 39-51.
150. Von Delwig A., Bailey E., Gibbs D. M. and Robinson J. H. (2002): The route of bacterial uptake by macrophages influences the repertoire of epitopes presented to CD4 T cells. Eur. J. Immunol., 32, 3714-3719.
151. Walker P. R., Kokileva L., LeBlanc J. and Sikorska M. (1993): Detection of the initial stages of DNA fragmentation in apoptosis. Biotechniques, 15, 1032-1040.
152. Wang J. and Fu Y. X. (2003): LIGHT (a cellular ligand for herpes virus entry mediator and lymphotoxin receptor)-mediated thymocyte deletion Is dependent on the interaction between TCR and MHC/self-peptide. J. Immunol., 170, 3986-3993.
153. Ward S. G. and Cantrell D. A. (2001): Phosphoinositide 3-kinases in T lymphocyte activation. Curr. Opin. Immunol., 13, 332-338.
154. Werlen G. and Palmer E. (2002): The TCR signalosome: a dynamic structure with expanding complexity. Curr. Opin. Immunol., 14, 299-305.
155. Williamson E., Westrich G. M. and Viney J. L. (1999): Modulating dendritic cells to optimize mucosal immunization protocols. J. Immunol., 163, 3668-3675.
156. Wyllie A. H., Morris R. G., Smith A. L. and Dunlop D. (1984): Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol., 142, 67-77.
157. Yoshida R., Imai T., Hieshima K., Kusuda J., Baba M., Kitaura M., Nishimura M., Kakizaki Ni., Nomiyama H. and Yoshie O. (1997): Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J. Biol. Chem., 272, 13803-13809.
158. Yoshida R., Nagira M., Imai T., Baba M., Takagi S., Tabira Y., Akagi J., Nomiyama H. and Yoshie O. (1998): EBI1-ligand chemokine (ELC) attracts a broad spectrum of lymphocytes: activated T cells strongly up-regulate CCR7 and efficiently migrate toward ELC. Int. Immunol., 10, 901-910.
159. Zell T. and Jenkins M. K. (2002): Flow cytometric analysis of T cell receptor signal transduction. Sci. STKE, 128, PL5.
160. Zell T., Khoruts A., Ingulli E., Bonnevier J., Mueller D. and Jenkins M. (2001): single cell analysis of signal transduction in CD4 T cells stimulated by antigen in vivo. Proc. Natl. Acad. Sci. USA, 98, 10805-10810.
161. Zhang J., Salojin K., Gao J.-X., Cameron M., Bergerot I. and Delovitch T. (1999): p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T-cells. J. Immunol., 162, 3819-3829.
162. + regulatory T cells by oral antigen administration. J. Immunol., 167, 4245-4253.
163. Zheng B., Han S. and Kelsoe G. (1996): T helper cells in murine germinal centers are antigen-specific emigrants that downregulate Thy-1. J. Exp. Med., 184, 1083-1091.
164. Zinkernagel R. M. and Doherty P. C. (1997): The discovery of MHC restriction. Immunol. Today, 18, 14-17.